A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Mylan, the profiteering, tax-dodging drug company currently taking immense heat for jacking up the price of its Epipen by 500%, announced Thursday that it will help more patients cover their ...

Mylan's generic version will hit shelves within several weeks at a list price of $300 for a two-pack carton in dosages of either 0.15 milligrams or 0.30 mg, the company said.

Mylan NV is poised to lose its hostile bid for Perrigo Co., people familiar with the matter said, a rare outcome in one of the bitterest takeover battles in decades.

Mylan also said it would offer a $25 discount on the co-pays for buyers with health insurance, and a savings card good for a discount of up to $300 on deductible or co-pay expenses for the branded ...

Mylan Inc., based in suburban Pittsburgh, became Netherlands-based Mylan N.V. last year to reduce its U.S. income taxes. But when you take a close look at Mylan’s business, it depends heavily on ...

Mylan raised EpiPen prices "to get filthy rich at the expense of our constituents," Rep. Elijah Cummings, D-Md., said at the House Oversight Committee hearing. Bresch, however, stood her ground ...

Mylan NV, whose price increases on its lifesaving EpiPen drug drew broad criticism this month, said Monday it would launch a half-priced generic version of the medicine—in effect, competing ...